Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2014

Branda JA, Rychert J, Burnham C-, Bythrow M, Garner OB, Ginocchio CC, et al. Multicenter validation of the VITEK MS v2.0 MALDI-TOF mass spectrometry system for the identification of fastidious gram-negative bacteria. Diagn Microbiol Infect Dis. 2014;78(2):129-31.

Cohn CS, Stubbs J, Schwartz J, Francis R, Goss C, Cushing M, et al. A comparison of adverse reaction rates for PAS C versus plasma platelet units. Transfusion. 2014;54(8):1927-34.

Samad A, Attam R, Jessurun J, Pambuccian SE. Psammoma bodies and abundant stromal amyloid in an endoscopic ultrasound guided fine needle aspirate (EUS-FNA) of a pancreatic neuroendocrine tumor: a potential pitfall. Diagn Cytopathol. 2014;42(9):766-71.

Valencia T, Kim JY, Abu-Baker S, Moscat-Pardos J, Ahn CS, Reina-Campos M, et al. Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis. Cancer Cell. 2014;26(1):121-135.

DeSimone RA, Ginter PS, Chen Y-. Granular cell tumor of the breast eliciting exuberant pseudoepitheliomatous hyperplasia. Int J Surg Pathol. 2014;22(2):156-7.

Geyer JT, Subramaniyam S. Micronuclei and nuclear budding in chronic lymphocytic leukaemia. Br J Haematol. 2014;167(5):585.

Galletti G, Matov A, Beltran H, Fontugne J, Mosquera JM, Cheung C, et al. ERG induces taxane resistance in castration-resistant prostate cancer. Nat Commun. 2014;5:5548.

Greenblatt MB, Torre M, Means J, Tanasijevic M, Pedulla LV, Bunnell CA, et al. Use of potassium concentrations as a quality-of-service metric for phlebotomists detects systematic preanalytical biases and facilitates their correction. Clin Chem. 2014;60(11):1453-5.

Park K, Chen Z, MacDonald TY, Siddiqui J, Ye H, Erbersdobler A, et al. Prostate cancer with Paneth cell-like neuroendocrine differentiation has recognizable histomorphology and harbors AURKA gene amplification. Hum Pathol. 2014;45(10):2136-43.

Vitolo U, Chiappella A, Franceschetti S, Carella AM, Baldi I, Inghirami G, et al. Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial. Lancet Oncol. 2014;15(7):730-7.